These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy]. Martin T; Taupignon A; Lavignolle A; Perrin D; Le Bodic L Gastroenterol Clin Biol; 1991; 15(11):833-7. PubMed ID: 1769473 [TBL] [Abstract][Full Text] [Related]
3. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. Lindholt JS; Henneberg EW; Juul S; Fasting H Int Angiol; 1999 Mar; 18(1):52-7. PubMed ID: 10392481 [TBL] [Abstract][Full Text] [Related]
17. [Prevention of digestive hemorrhage recurrence in hepatic cirrhosis with propranolol. A 4 years' follow-up study]. Jirón MI; Soto JR; Wolff C; Armas R Rev Med Chil; 1993 Feb; 121(2):133-8. PubMed ID: 8303108 [TBL] [Abstract][Full Text] [Related]
18. [Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study]. Dollet JM; Champigneulle B; Patris A; Bigard MA; Gaucher P Gastroenterol Clin Biol; 1988 Mar; 12(3):234-9. PubMed ID: 3259521 [TBL] [Abstract][Full Text] [Related]